Session Information

  • WCLC 2022

    2022 World Conference on Lung Cancer

    As an IASLC member, you can enjoy complimentary access to the presentations from the World Conference on Lung Cancer 2022. If you participated in the conference, kindly utilize the code "WCLC2022ACCESSFULL" to enter the virtual meeting and access the recordings.

    Presentation Date(s):  
    • August 6 - 9, 2022
    • Total Presentations: 2015

    All times listed are in Vienna, Austria Time, CEST (UTC+2:00)

    PL - Plenary
    IBS - Interactive Breakfast Session (in-person attendees only)
    ES - Education Session
    OA - Oral Session
    MA - Mini Oral Session
    P - Posters
    EP - ePosters
    WS - Workshops
    LA – Lectureship Awards
    IS - Industry Symposium

Filter Results:

Show Only CME Accredited Sessions

  • +

    OA05 - The Granularity of Lung Cancer Screening Implementation

    • 15:45 - 16:45
    • 8/07/2022
    • Location: Hall C7
    • Not for CME Credit
    • Type: Oral
    • Track: Early Detection and Screening
    • +

      OA05.05 - China Lung Cancer Screening (CLUS) Version 1.0: Mortality, Survival and Incidence Rates with Long-Term Follow-up

      16:07 - 16:17  |  Presenter: Fangfei Qian

      • Abstract

      Loading...

  • +

    EP01.03 - Early Detection and Screening - Implementation

    • 09:45 - 18:00
    • 8/07/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: E-Poster
    • Track: Early Detection and Screening - Implementation
    • +

      EP01.03-010 - China Lung Cancer Screening Study (CLUS) Version 2.0: Study Design and Baseline Screening Results

      Presenter: Fangfei Qian

      • Abstract

      Loading...

  • +

    EP16.02 - Tumor Biology and Biomarkers - Minimally Invasive Biomarkers

    • 09:45 - 18:00
    • 8/07/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: E-Poster
    • Track: Tumor Biology and Biomarkers - Minimally Invasive Biomarkers
    • +

      EP16.02-023 - Extracellular Vesicles Long RNA Sequencing as Diagnostic Biomarkers for Lung Adenocarcinoma Patients with Tumor Size Smaller than 2cm

      Presenter: Fangfei Qian

      • Abstract

      Loading...